Literature DB >> 3258952

Epidermal growth factor-like proteins in breast fluid and human milk.

J M Connolly1, D P Rose.   

Abstract

Epidermal growth factor (EGF), and the transforming growth factor-alpha (TGF-alpha) family of proteins, which also bind to the EGF receptor, have been associated with human breast cancer. The total EGF-like proteins were determined by a radioreceptor assay, and TGF-alpha by radioimmunoassay, in human milk and breast fluid samples. The breast fluids were collected by nipple aspiration from healthy premenopausal women. Both the 24 milks and 18 breast fluids assayed contained EGF-like proteins, at concentrations ranging from 32-600 ng/ml (median, 140 ng/ml), and 62-654 ng/ml (median, 205 ng/ml) respectively. Immunoreactive TGF-alpha proteins were detected at higher levels in 21 breast fluids (range, 0-50.0; median 5.1 ng/ml) than in 24 milk samples (range, 0-8.4; median, 0.8 ng/ml).

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3258952     DOI: 10.1016/0024-3205(88)90041-0

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  9 in total

Review 1.  Current concepts regarding the pathogenesis of necrotizing enterocolitis.

Authors:  Mikael Petrosyan; Yigit S Guner; Monica Williams; Anatoly Grishin; Henri R Ford
Journal:  Pediatr Surg Int       Date:  2009-03-20       Impact factor: 1.827

Review 2.  Milk epidermal growth factor and gut protection.

Authors:  Bohuslav Dvorak
Journal:  J Pediatr       Date:  2010-02       Impact factor: 4.406

3.  Mechanism of p38 MAPK-induced EGFR endocytosis and its crosstalk with ligand-induced pathways.

Authors:  Mireia Perez Verdaguer; Tian Zhang; Joao A Paulo; Steven Gygi; Simon C Watkins; Hiroaki Sakurai; Alexander Sorkin
Journal:  J Cell Biol       Date:  2021-05-25       Impact factor: 10.539

Review 4.  Ductal approaches to assessment and management of women at high risk for developing breast cancer.

Authors:  Imogen Locke; Gillian Mitchell; Rosalind Eeles
Journal:  Breast Cancer Res       Date:  2004-01-26       Impact factor: 6.466

5.  Breast milk protects against the development of necrotizing enterocolitis through inhibition of Toll-like receptor 4 in the intestinal epithelium via activation of the epidermal growth factor receptor.

Authors:  M Good; C P Sodhi; C E Egan; A Afrazi; H Jia; Y Yamaguchi; P Lu; M F Branca; C Ma; T Prindle; S Mielo; A Pompa; Z Hodzic; J A Ozolek; D J Hackam
Journal:  Mucosal Immunol       Date:  2015-04-22       Impact factor: 7.313

6.  EGF receptor signaling, phosphorylation, ubiquitylation and endocytosis in tumors in vivo.

Authors:  Itziar Pinilla-Macua; Alexandre Grassart; Umamaheswar Duvvuri; Simon C Watkins; Alexander Sorkin
Journal:  Elife       Date:  2017-12-21       Impact factor: 8.140

7.  What's Normal? Immune Profiling of Human Milk from Healthy Women Living in Different Geographical and Socioeconomic Settings.

Authors:  Lorena Ruiz; Irene Espinosa-Martos; Cristina García-Carral; Susana Manzano; Michelle K McGuire; Courtney L Meehan; Mark A McGuire; Janet E Williams; James Foster; Daniel W Sellen; Elizabeth W Kamau-Mbuthia; Egidioh W Kamundia; Samwel Mbugua; Sophie E Moore; Linda J Kvist; Gloria E Otoo; Kimberly A Lackey; Katherine Flores; Rossina G Pareja; Lars Bode; Juan M Rodríguez
Journal:  Front Immunol       Date:  2017-06-30       Impact factor: 7.561

8.  Generation of endogenous pH-sensitive EGF receptor and its application in high-throughput screening for proteins involved in clathrin-mediated endocytosis.

Authors:  Mads Breum Larsen; Mireia Perez Verdaguer; Brigitte F Schmidt; Marcel P Bruchez; Simon C Watkins; Alexander Sorkin
Journal:  Elife       Date:  2019-05-08       Impact factor: 8.140

9.  Genetic Modification of CD8+ T Cells to Express EGFR: Potential Application for Adoptive T Cell Therapies.

Authors:  Teresa Lozano; Silvia Chocarro; Celia Martin; Aritz Lasarte-Cia; Cynthia Del Valle; Marta Gorraiz; Patricia Sarrión; Marina Ruiz de Galarreta; Amaia Lujambio; Sandra Hervás-Stubbs; Pablo Sarobe; Noelia Casares; Juan J Lasarte
Journal:  Front Immunol       Date:  2019-12-20       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.